Literature DB >> 22286307

Preexisting influenza-specific CD4+ T cells correlate with disease protection against influenza challenge in humans.

Tom M Wilkinson1, Chris K F Li, Cecilia S C Chui, Arthur K Y Huang, Molly Perkins, Julia C Liebner, Rob Lambkin-Williams, Anthony Gilbert, John Oxford, Ben Nicholas, Karl J Staples, Tao Dong, Daniel C Douek, Andrew J McMichael, Xiao-Ning Xu.   

Abstract

Protective immunity against influenza virus infection is mediated by neutralizing antibodies, but the precise role of T cells in human influenza immunity is uncertain. We conducted influenza infection studies in healthy volunteers with no detectable antibodies to the challenge viruses H3N2 or H1N1. We mapped T cell responses to influenza before and during infection. We found a large increase in influenza-specific T cell responses by day 7, when virus was completely cleared from nasal samples and serum antibodies were still undetectable. Preexisting CD4+, but not CD8+, T cells responding to influenza internal proteins were associated with lower virus shedding and less severe illness. These CD4+ cells also responded to pandemic H1N1 (A/CA/07/2009) peptides and showed evidence of cytotoxic activity. These cells are an important statistical correlate of homotypic and heterotypic response and may limit severity of influenza infection by new strains in the absence of specific antibody responses. Our results provide information that may aid the design of future vaccines against emerging influenza strains.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22286307     DOI: 10.1038/nm.2612

Source DB:  PubMed          Journal:  Nat Med        ISSN: 1078-8956            Impact factor:   53.440


  41 in total

Review 1.  Safety and efficacy of live attenuated, cold-adapted, influenza vaccine-trivalent.

Authors:  Robert B Belshe; Paul M Mendelman
Journal:  Immunol Allergy Clin North Am       Date:  2003-11       Impact factor: 3.479

Review 2.  Helping the CD8(+) T-cell response.

Authors:  Michael J Bevan
Journal:  Nat Rev Immunol       Date:  2004-08       Impact factor: 53.106

3.  Identification of T-cell epitopes using ELISpot and peptide pool arrays.

Authors:  Timothy W Tobery; Michael J Caulfield
Journal:  Methods Mol Med       Date:  2004

Review 4.  Emerging infections: pandemic influenza.

Authors:  W P Glezen
Journal:  Epidemiol Rev       Date:  1996       Impact factor: 6.222

Review 5.  Hallmarks of CD4 T cell immunity against influenza.

Authors:  K K McKinstry; T M Strutt; S L Swain
Journal:  J Intern Med       Date:  2011-03-25       Impact factor: 8.989

6.  Primary influenza A virus infection induces cross-protective immunity against a lethal infection with a heterosubtypic virus strain in mice.

Authors:  J H C M Kreijtz; R Bodewes; G van Amerongen; T Kuiken; R A M Fouchier; A D M E Osterhaus; G F Rimmelzwaan
Journal:  Vaccine       Date:  2006-09-07       Impact factor: 3.641

Review 7.  An overview of serum antibody responses to influenza virus antigens.

Authors:  R B Couch
Journal:  Dev Biol (Basel)       Date:  2003

8.  CD8(+) T lymphocyte mobilization to virus-infected tissue requires CD4(+) T-cell help.

Authors:  Yusuke Nakanishi; Bao Lu; Craig Gerard; Akiko Iwasaki
Journal:  Nature       Date:  2009-11-08       Impact factor: 49.962

9.  Effector T cells control lung inflammation during acute influenza virus infection by producing IL-10.

Authors:  Jie Sun; Rajat Madan; Christopher L Karp; Thomas J Braciale
Journal:  Nat Med       Date:  2009-02-22       Impact factor: 53.440

10.  The natural viral load profile of patients with pandemic 2009 influenza A(H1N1) and the effect of oseltamivir treatment.

Authors:  Iris W Li; Ivan F Hung; Kelvin K To; Kwok-Hung Chan; Samson S Y Wong; Jasper F Chan; Vincent C Cheng; Owen T Tsang; Sik-To Lai; Yu-Lung Lau; Kwok-Yung Yuen
Journal:  Chest       Date:  2010-01-08       Impact factor: 9.410

View more
  475 in total

1.  CD4+ T cells limit the damage in influenza.

Authors:  Anne Kelso
Journal:  Nat Med       Date:  2012-02-06       Impact factor: 53.440

2.  Report on the second WHO integrated meeting on development and clinical trials of influenza vaccines that induce broadly protective and long-lasting immune responses: Geneva, Switzerland, 5-7 May 2014.

Authors:  Nancy J Cox; Julian Hickling; Rebecca Jones; Guus F Rimmelzwaan; Linda C Lambert; John Boslego; Larisa Rudenko; Leena Yeolekar; James S Robertson; Joachim Hombach; Justin R Ortiz
Journal:  Vaccine       Date:  2015-10-23       Impact factor: 3.641

3.  Epitope specific T-cell responses against influenza A in a healthy population.

Authors:  Miloje Savic; Jennifer L Dembinski; Yohan Kim; Gro Tunheim; Rebecca J Cox; Fredrik Oftung; Bjoern Peters; Siri Mjaaland
Journal:  Immunology       Date:  2015-12-08       Impact factor: 7.397

Review 4.  Progress on adenovirus-vectored universal influenza vaccines.

Authors:  Kui Xiang; Guan Ying; Zhou Yan; Yan Shanshan; Zhang Lei; Li Hongjun; Sun Maosheng
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

Review 5.  H5N1 vaccines in humans.

Authors:  Mariana Baz; Catherine J Luke; Xing Cheng; Hong Jin; Kanta Subbarao
Journal:  Virus Res       Date:  2013-05-28       Impact factor: 3.303

6.  Cytokine-dependent induction of CD4+ T cells with cytotoxic potential during influenza virus infection.

Authors:  Laiqing Hua; Shuyu Yao; Duy Pham; Li Jiang; Jeffrey Wright; Deepali Sawant; Alexander L Dent; Thomas J Braciale; Mark H Kaplan; Jie Sun
Journal:  J Virol       Date:  2013-08-28       Impact factor: 5.103

7.  Differential influenza H1N1-specific humoral and cellular response kinetics in kidney transplant patients.

Authors:  Vinay Rambal; Karin Müller; Chantip Dang-Heine; Arne Sattler; Mikalai Dziubianau; Benjamin Weist; Si-Hong Luu; Alexandra Stoyanova; Peter Nickel; Andreas Thiel; Avidan Neumann; Brunhilde Schweiger; Petra Reinke; Nina Babel
Journal:  Med Microbiol Immunol       Date:  2013-09-22       Impact factor: 3.402

8.  Flow Cytometric and Cytokine ELISpot Approaches To Characterize the Cell-Mediated Immune Response in Ferrets following Influenza Virus Infection.

Authors:  Anthony DiPiazza; Katherine Richards; Frances Batarse; Laura Lockard; Hui Zeng; Adolfo García-Sastre; Randy A Albrecht; Andrea J Sant
Journal:  J Virol       Date:  2016-08-12       Impact factor: 5.103

9.  Synthetic Toll-Like Receptor 4 (TLR4) and TLR7 Ligands Work Additively via MyD88 To Induce Protective Antiviral Immunity in Mice.

Authors:  Peter H Goff; Tomoko Hayashi; Wenqian He; Shiyin Yao; Howard B Cottam; Gene S Tan; Brian Crain; Florian Krammer; Karen Messer; Minya Pu; Dennis A Carson; Peter Palese; Maripat Corr
Journal:  J Virol       Date:  2017-09-12       Impact factor: 5.103

Review 10.  Harnessing CD4⁺ T cell responses in HIV vaccine development.

Authors:  Hendrik Streeck; M Patricia D'Souza; Dan R Littman; Shane Crotty
Journal:  Nat Med       Date:  2013-02-06       Impact factor: 53.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.